Redefining medical treatment in the management of unstable angina (Q34074021)

30 July 2017

1 reference

title

Redefining medical treatment in the management of unstable angina (English)

1 reference

30 July 2017

1 reference

30 July 2017

R M Califf

1 reference

30 July 2017

E Braunwald

1 reference

30 July 2017

H D White

1 reference

30 July 2017

C P Cannon

1 reference

30 July 2017

K A Fox

1 reference

30 July 2017

V Fuster

1 reference

30 July 2017

W B Gibler

1 reference

30 July 2017

R A Harrington

1 reference

30 July 2017

S B King

1 reference

30 July 2017

N S Kleiman

1 reference

30 July 2017

P Theroux

1 reference

30 July 2017

F Van de Werf

1 reference

30 July 2017

J T Willerson

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

American Journal of Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

108

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

41-53

1 reference

Unstable Angina : An Etiologic Approach to Management

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Direct medical costs of coronary artery disease in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

The clinical course of patients with acute myocardial infarction who are unsuitable for thrombolytic therapy because of the presenting electrocardiogram. UK Heart Attack Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Unstable angina. A classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Incidence and follow-up of Braunwald subgroups in unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Unstable angina: good long-term outcome after a complicated early course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Correlation of angiographic morphology and clinical presentation in unstable angina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Correlation between clinical and morphologic findings in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Clinical predictors of unstable coronary lesion morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Predictive Validity of the Braunwald Classification of Unstable Angina for Angiographic Findings, Short-Term Prognoses, and Treatment Selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Pathophysiology and management of unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Predictors of risk in patients with unstable angina admitted to a district general hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Unstable angina: relationship of clinical presentation, coronary artery pathology, and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

A new clinical classification for hospital prognosis of unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Inv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Cardiac troponins in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

The Prognostic Value of Serum Troponin T in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Prognostic value of cardiac troponin T in unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Elevation of C-reactive protein in "active" coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

C-reactive protein elevation and early outcome in patients with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Antiplatelet and anticoagulant use after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Reactivation of unstable angina after the discontinuation of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Low-Molecular-Weight Heparins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Comparison of heparin therapy for < or = 48 hours to > 48 hours in unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

Monitoring Platelet GP IIb/IIIa Antagonist Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900416-7

10.1016/S0002-9343(99)00416-7

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference